Bone Cement Market Analysis and Opportunities by 2028

The bone cement market is projected to reach US$ 1,626.52 million by 2028 from US$ 1,103.00 million in 2021. It is expected to grow at a CAGR of 5.7% from 2021 to 2028.  

Bone cement is used to fix prostheses to the bone in orthopedic musculoskeletal surgical procedures for osteoporosis, osteoarthritis, rheumatoid arthritis, traumatic arthritis, vascular necrosis, severe joint destruction secondary to trauma, collagen disease, and revision of previous arthroplasty procedures.

The bone cement market is analyzed on the basis of product type, application, end user, and geography. By geography, the bone cement market is broadly segmented into North America, Europe, Asia Pacific, the Middle East and Africa (MEA), and South and Central America. The report offers insights and in-depth analysis of the bone cement market, emphasizing parameters, such as market trends, technological advancements, and market dynamics, along with the analysis of the competitive landscape of the world's leading market players.        

Published Report - Bone Cement Market: Strategic Insights

Lucrative Regions for Bone Cement Market

Market Insights

Rising Prevalence of Osteoporosis Drives Bone Cement Market Growth

Osteoporosis is characterized by low bone density and deterioration of bone tissue. Osteoporosis increases the risk of fractures. In recent years, there have been growing cases of osteoporosis. For instance, according to an article published by Restore Programme in October 2020, each year, osteoporosis causes more than 8.9 million fractures globally, which corresponds to one every three seconds, with one in three women and one in five men over 50 suffering from an osteoporotic fracture.

In addition, according to the International Osteoporosis Foundation, the global incidence of hip fracture is projected to grow by 240% in women and 310% in men by 2050, compared to rates in 1990. It is estimated that more than about 50% of all osteoporotic hip fractures are likely to occur in Asia by 2050. Moreover, in the 29 countries of Europe (European Union + Switzerland and the UK), the number of new fragility fractures was expected to reach 4.3 million in 2019 as per the data of International Osteoporosis Foundation, with 826,708 hip fractures (19%), 636,705 forearm fractures (15%), 662,544 vertebral fractures (16%), and 2,149,591 other fractures (50% ). Similarly, between 2019 and 2034, the population aged 50 and up is expected to grow by 11.4%. The population aged 75 and above increased significantly, with 29.6% in women and 42.6% in men.

Based on the fracture counts, determined from age- and sex-specific incidence and population size in 5-year age intervals, the annual number of osteoporotic fractures in the 29 countries of Europe (European Union + Switzerland and the UK), is predicted to increase by 1.06 million, from 4.28 million in 2019 to 5.34 million in 2034. The percentage rise throughout the 15 years will vary significantly by country, ranging from a moderate 8% growth in Latvia to a spectacular 58% growth in Ireland.

Osteoporosis leads to increased occurrence of fractures and procedures of the joint. Hence, the rising prevalence of osteoporosis is boosting the demand and sales of bone cement, contributing to the growth of the bone cement market.

Rising Demand for Arthroplasty Contributes Significantly to Bone Cement Market Growth

Arthroplasty is a procedure performed to restore the function of a joint by bringing about realignment and restoration. In recent years, arthroplasty procedures have increased due to advancements in the type of technology being used. According to the American Association of Neurological Surgeons, about 75,000 people suffer from vertebral compression fractures each year.

Distribution of Arthroplasty Procedures According to American Academy of Orthopedic Surgeons, 2012–2019

Source: The Insight Partners Analysis, Primary Interviews, Magazines and Journals, and Secondary Sources

Furthermore, according to Canadian Institute for Health Information (CIHI), hip and knee replacements are still the two prevalent procedures in Canada, with more than 138,000 surgeries performed annually.

Arthroplasty is performed when medical treatments fall short to relieve the pain and restore the functioning of the joint. Hence, it has been preferred in recent years. The increase in the number of arthroplasty procedures is anticipated to drive the demand for bone cement during the forecast period.

Type Insights

Based on type, the global bone cement market is segmented into polymethyl methacrylate (PMMA) cement, calcium phosphate cement (CPC), and glass polyalkenoate cement (GPC). In 2020, the polymethyl methacrylate (PMMA) cement segment held the largest share of the market. Moreover, the calcium phosphate cement (CPC) segment market is expected to grow at the highest CAGR during the period from 2021 to 2028. PMMA is a plastic with excellent mechanical properties and minimal toxicity. It is popular for hip-joint transplants because of its inert properties, but it degrades slowly. There is an increasing demand for PMMA bone cement due to its extensive use in various orthopedic procedures, such as arthroplasty, kyphoplasty, and vertebroplasty. The surge in demand for the polymethyl methacrylate (PMMA) cement is bolstering this segment's market

Application Insights

Based on application, the bone cement market is segmented into arthroplasty, kyphoplasty, and vertebroplasty. The arthroplasty segment held the largest bone cement market share in 2020, and it is further expected to be the largest shareholder in the bone cement market by 2028. Arthroplasty is performed when medical treatments fall short to relieve the pain and restore the functioning of the joint. Hence, it has been preferred in recent years. The surge in demand for arthroplasty is bolstering this segment's market.

End-use Insights

Based on end user, the bone cement market is segmented into hospitals, ambulatory surgery centers (ASCs), and clinics. The hospital segment held the largest market share in 2020, and it is further expected to be the largest shareholder in the market by 2028. The growth of the segments is attributed to the growing number of cases of osteoporosis. Hospitals are the primary healthcare centers where orthopedic surgeries, such as kyphoplasty, arthroplasty, and vertebroplasty, are extensively treated, which bolstered the market growth of this segment.

Bone Cement Market, by Type – 2021 and 2028

Product launches and mergers and acquisitions are the highly adopted strategies by the players operating in the global bone cement market. A few of the recent key product developments are listed below:

• In January 2021, Zimmer Biomet won a US International Trade Commission case, in which, it was accused of stealing Heraeus trade secrets for bone cement–the compound used to fill the gap between an artificial joint and a bone. The commission rejected Heraeus Holding's request to block the imports of Refobacin bone cement made in France that competes with Heraeus's PALACOS product.
• In July 2021, Arthrex, Inc. entered into a distribution agreement with Celularity Inc. to distribute and commercialize Celularity's placental-derived biomaterial products for orthopedics and sports medicine in the US. Under the terms of the deal, Celularity provided Arthrex with exclusive commercial distribution rights for orthopedic surgery and sports medicine and continued to be responsible for product manufacturing and supply.

Several companies have experienced severe losses in the last quarter of 2019; they have also negatively influenced the first and second quarters of 2020. Hence, the impact of COVID 19 on the bone cement market was immediate and drastic. The businesses in the region are hampered due to disruption in the supply chain and an increase in demand. To reduce COVID 19 infection in hospitals and clinics, healthcare practitioners and patients are adopting and preferring remote patient treatment. Under these unforeseeable circumstances, the orthopedic practice could not remain unaffected. Many surgical treatments and non-urgent consultations were canceled or postponed. Elective surgery was suspended in many institutions, and the overall volume of orthopedic cases fell dramatically to limit the spread of the virus and reserve and reallocate resources in healthcare personnel (nurses, anesthesiologists), medical equipment (personal protective equipment, ventilators), and beds. Even when hospitals resumed elective surgeries, cases were prioritized based on clinical urgency, causing severe delays in regular and time-sensitive elective care for orthopedic patients.

Bone Cement Market – Segmentation

Bone Cement Market - By Type

• Polymethyl Methacrylate (PMMA) Cement
• Calcium Phosphate Cement (CPC)
• Glass Polyalkenoate Cement (GPC)
• Others

Bone Cement Market - By Application

• Arthroplasty
• Kyphoplasty
• Vertebroplasty

Bone Cement Market - By Geography

• North America
  • US
  • Canada
  • Mexico
• Europe
  • France
  • Germany
  • UK
  • Italy
  • Spain
  • Rest of Europe
• Asia Pacific (APAC)
  • China
  • Japan
  • India
  • Australia
  • South Korea
  • Rest of Asia Pacific
• Middle East & Africa (MEA)
  • Saudi Arabia
  • South Africa
  • UAE
  • Rest of the Middle East & Africa
• South and Central America (SCAM)
  • Brazil
  • Argentina
  • Rest of South and Central America

Bone Cement Market - Company Profiles

• DePuy Synthes (The Orthopedics Company of Johnson & Johnson)
• Zimmer Biomet
• Stryker Corporation
• Smith & Nephew
• DJO Global, Inc.
• Arthrex, Inc. 
• Tecres S.p.A.
• Heraeus Holding GmbH
• Teknimed
• Cardinal Health Inc.

Published Report - Bone Cement Market Players Density: Understanding Its Impact on Business Dynamics

The Published Report - Bone Cement Market is growing rapidly, driven by increasing end-user demand due to factors such as evolving consumer preferences, technological advancements, and greater awareness of the product's benefits. As demand rises, businesses are expanding their offerings, innovating to meet consumer needs, and capitalizing on emerging trends, which further fuels market growth.